Oramed Pharmaceuticals Inc. (ORMP) Stock Forecast
ORMP analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $7.00 average of analyst targets
- Upside to target
- +72.0% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $0.43
- 52-week range
- $2.19 – $5.34
ORMP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ORMP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.43 | $0.43 | $0.43 | $1.13 | −62.0% | 1 |
| Current fiscal year (2026) | $4.47 | $4.47 | $4.47 | $1.50 | +198.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ORMP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | −100.0% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | — | — |
ORMP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ORMP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.52 | $0.52 | $0.52 | $0.43 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.00 | $2.31 | $2.31 | $2.31 | $4.47 | — | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ORMP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ORMP beat in 7 of 11.
What analysts expect from ORMP
The average price target is $7.00, 72.0% above the latest close of $4.07. Analysts expect earnings of $4.47 per share for 2026, +198.0% from a year earlier. Oramed Pharmaceuticals beat the EPS estimate in 7 of the last 11 quarters.
Related: ORMP income statement, ORMP key metrics, ORMP chart. See the ORMP stock overview for the latest quote and news.
ORMP forecast FAQ
What is Oramed Pharmaceuticals's price target?
The average analyst price target for Oramed Pharmaceuticals is $7.00, 72.0% above the latest close of $4.07.
What is Oramed Pharmaceuticals's EPS forecast?
Analysts forecast $4.47 per share for 2026 (range $4.47 to $4.47).
When does Oramed Pharmaceuticals report earnings?
Oramed Pharmaceuticals is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $0.43.
Does Oramed Pharmaceuticals usually beat earnings estimates?
Oramed Pharmaceuticals reported EPS at or above the analyst estimate in 7 of the last 11 quarters.